RELATIONSHIP OF DURATION AND ONSET OF DIABETES TO PREVALENCE OF DIABETIC-RETINOPATHY

被引：51

作者：

JERNELD, B ^{[1
]}

ALGVERE, P ^{[1
]}

机构：

[1] KAROLINSKA INST, DEPT OPHTHALMOL, S-10401 STOCKHOLM 60, SWEDEN

来源：

AMERICAN JOURNAL OF OPHTHALMOLOGY | 1986年 / 102卷 / 04期

关键词：

D O I：

10.1016/0002-9394(86)90069-3

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

引用

页码：431 / 437

页数：7

共 27 条

[1]

AIELLO LM, 1981, OPHTHALMOLOGY, V88, P619

[2]

[Anonymous], 1978, Ophthalmology, V85, P82

[3]

[Anonymous], 1981, OPHTHALMOLOGY, V88, P583

[4] UTILIZATION OF ANTI-DIABETIC DRUGS IN ISLAND OF GOTLAND, SWEDEN - AGREEMENT BETWEEN WHOLESALE FIGURES AND PRESCRIPTION DATA [J].

BERGMAN, U .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 14 (03) :213-220

[5]

BERKOW J W, 1977, International Ophthalmology Clinics, V17, P89, DOI 10.1097/00004397-197701720-00008

[6] ASSESSING THE RISK OF DIABETIC-RETINOPATHY [J].

CONSTABLE, IJ ;

KNUIMAN, MW ;

WELBORN, TA ;

COOPER, RL ;

STANTON, KM ;

MCCANN, VJ ;

GROSE, GC .

AMERICAN JOURNAL OF OPHTHALMOLOGY, 1984, 97 (01) :53-61

[7]

COX DR, 1970, ANAL BINARY DATA, P1

[8]

DANIELSEN R, 1982, ACTA MED SCAND, V212, P277

[9]

GREEN A, 1981, DIABETOLOGIA, V20, P468

[10]

HERIOT WJ, 1983, AUST J OPHTHALMOL, V11, P175

← 1 2 3 →